Reestablish of active immune towards to hepatitis B virus after liver transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-PNC-10001706

Enrollment

Unknown

Registered

2010-11-04

Start date

2006-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B

Interventions

1:HBV-Vaccine injection

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Post-transplantation time was at least 18 months; 2) Patients were receiving a combined prevention regimen using nucleoside analogues and HBIG; 3) Liver function was normal or essentially normal; and 4) Immunosuppression status was low.

Exclusion criteria

Exclusion criteria: Recurrence of primary disease

Design outcomes

Primary

Measure	Time frame
Titer of serum anti-HBs;Positive rate of anti-HBs;	—

Countries

China

Contacts

Public ContactLu shichun

lsc620213@yahoo.com.cn+86 13381310573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026